The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction
被引:117
作者:
Lupher, ML
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
Lupher, ML
Rao, N
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
Rao, N
Eck, MJ
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
Eck, MJ
Band, H
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
Band, H
机构:
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[3] Massachusetts Dept Publ Hlth, Boston, MA 02111 USA
来源:
IMMUNOLOGY TODAY
|
1999年
/
20卷
/
08期
基金:
美国国家卫生研究院;
关键词:
D O I:
10.1016/S0167-5699(99)01484-X
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The Cbl protooncoprotein has recently emerged as a component of tyrosine kinase-mediated signal transduction in a variety of cell types. Here, we discuss evidence that supports a role for Cbl as a novel negative regulator of immune receptor signaling, and present models for its mode of function.